Drugplain

atovaquone 750 mg/5mL

atovaquone · SUSPENSION · Glenmark Pharmaceuticals Inc., USA

No Recall History
Plain English

atovaquone is a suspension containing atovaquone at 750 mg/5mL, taken oral. Manufactured by Glenmark Pharmaceuticals Inc., USA.

Key Facts

Brand Name
atovaquone
Generic Name
atovaquone
NDC Code (Product)
68462-421
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Strength
750 mg/5mL
Dosage Form
SUSPENSION
Route
ORAL
Marketing Status
Application #
ANDA209685
Drug Class
Antimalarial [EPC]; Antiprotozoal [EPC]
Marketing Start
12/31/2017

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

off label use686 reports
drug ineffective369 reports
pyrexia354 reports
diarrhoea339 reports
pneumonia322 reports
nausea313 reports
condition aggravated246 reports
acute kidney injury235 reports
thrombocytopenia230 reports
death229 reports

Frequently Asked Questions

What is atovaquone used for?

atovaquone contains atovaquone. It is a suspension taken oral. Consult your doctor for specific uses.

Is atovaquone a controlled substance?

atovaquone is not classified as a controlled substance by the DEA.

What is the generic name for atovaquone?

The generic name for atovaquone is atovaquone. There are 12 other brand versions of atovaquone.

What is the NDC code for atovaquone 750 mg/5mL?

The NDC (National Drug Code) for atovaquone 750 mg/5mL is 68462-421, listed by Glenmark Pharmaceuticals Inc., USA.